Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - alpha lipoic acid,biotin,calcium pantothenate,choline bitartrate,cyanocobalamin,camellia sinensis,folic acid,inositol,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine nitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - alpha lipoic acid,biotin,calcium pantothenate,choline bitartrate,cyanocobalamin,camellia sinensis,folic acid,inositol,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine nitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

australian naturalcare products pty ltd - ascorbic acid,colecalciferol,calcium pantothenate,camellia sinensis,cyanocobalamin,d-alpha-tocopheryl acid succinate,dunaliella salina,folic acid,manganese amino acid chelate,pyridoxine hydrochloride,selenomethionine,silybum marianum,thiamine nitrate,vitis vinifera,zinc amino acid chelate -

Australia - English - Department of Health (Therapeutic Goods Administration)

australian naturalcare products pty ltd - ascorbic acid,colecalciferol,calcium pantothenate,camellia sinensis,cyanocobalamin,d-alpha-tocopheryl acid succinate,dunaliella salina,folic acid,manganese amino acid chelate,pyridoxine hydrochloride,selenomethionine,silybum marianum,thiamine nitrate,vitis vinifera,zinc amino acid chelate -

Australia - English - Department of Health (Therapeutic Goods Administration)

planet health pty ltd - arctium lappa,berberis vulgaris,colloidal anhydrous silica,calcium pantothenate,camellia sinensis,nicotinamide,pyridoxine hydrochloride,retinol acetate,zinc gluconate -

Malta - English - Medicines Authority

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - calcium pantothenate, cyanocobalamin, panax ginseng, nicotinamide, pyridoxine hydrochloride, thiamine hydrochloride, riboflavin sodium, phosphate - oral solution - calcium pantothenate 21.83 mg cyanocobalamin 0.01 mg panax ginseng 150 mg nicotinamide 20 mg pyridoxine hydrochloride 3.03 mg thiamine hydrochloride 2.24 mg riboflavin sodium phosphate 2.73 mg - tonics

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - brassica oleracea var. italica,calcium pantothenate,choline bitartrate,cyanocobalamin,camellia sinensis,cynara scolymus,folic acid,glycine,nicotinamide,pyridoxine hydrochloride,riboflavine,selenomethionine,silybum marianum,taurine,thiamine hydrochloride,triticum aestivum -

Australia - English - Department of Health (Therapeutic Goods Administration)

export corporation australia pty ltd - calcium pantothenate,chromium picolinate,cyanocobalamin,camellia sinensis,coffea arabica,coffea canephora,eleutherococcus senticosus,pyridoxine hydrochloride,piper nigrum,riboflavin,rubus idaeus,thiamine hydrochloride -

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c